Cortisol dynamics and endothelin-1/nitric oxide ratio are associated with clinical vasospasme

  • Julius July Department of Surgery, Medical Faculty of Pelita Harapan University, Neuroscience Centre Siloam Hospital Lippo Village Tangerang, Indonesia
  • Yesaya Yunus Department of Surgery, Medical Faculty of Pelita Harapan University, Neuroscience Centre Siloam Hospital Lippo Village Tangerang, Indonesia
  • Veli Sungono Department of Public Health, Medical Faculty of Pelita Harapan University, Tangerang, Indonesia
  • Suryani As’ad Department of Clinical Nutrition, Medical Faculty of Hasanuddin University, Makassar, Indonesia
  • Budhianto Suhadi Department of Clinical Pathology, Medical Faculty of Pelita Harapan University, Tangerang, Indonesia
  • Andi A. Islam Department of Neurosurgery Medical Faculty of Hasanuddin University, Makassar, Indonesia
DOI: https://doi.org/10.13181/mji.v22i3.585
Keywords: Cortisol dynamics, delayed ischemic neurological deficits, endothelin-1, nitric oxide
Abstract viewed: 1407 times
PDF downloaded: 546 times

Abstract

Background: Cortisol dynamics in serum might be related to clinical vasospasm, also known as delayed ischemic neurological deficits (DIND). Two vasoactive substances that play a role in pathophysiology of DIND are endothelin-1 (ET1) and nitric oxide (NO), both are proved associated with cortisol. This study aimed to know how cortisol play a role on ET1/NO ratio and its relationship to DIND.

Methods: This was a prospective cohort study for the first 14 days after aneurysmal subarachnoid hemorrhage (SAH). Patients with inclusion criteria will be enrolled for blood test before surgery, and post-operative day 2, 4, 7, and 10 (between 8:00-9:00 AM). The blood tests were performed for cortisol, ACTH, CBG, NO, and ET1. Free cortisol is calculated with Coolens equation. Logistic regression was used to see the interaction model and its scale. Bivariate analysis (corelation) was used to see the relationship between total cortisol, free cortisol, NO, ET1, and clinical vasospasm (DIND).

Results: Forty-four patients are enrolled into this study (20 male; 24 females). Mean age is 52.02 years (52.02 ± 11.23). There were 29 patients (66%) within  DIND group and 15 patients Non-DIND as the control group. The mean of cortisol level shown is significantly higher in DIND group (35.99 ± 14.24) µg/dL compared to Non-DIND group (19.57 ± 6.19) µg/dL, p < 0.001. The mean of free cortisol level was significantly higher in DIND group (2.06 ± 1.094) µg/dL compared to non-DIND group (0.838 ± 0.365 µg/dL; p < 0.001). The Scatter Plot graph show that correlation of cortisol with ET1/NO ratio started increasing on day 4 and became stronger on day 10.

Conclusion: Cortisol is associated with DIND following aneurysmal SAH, probably through its role in keeping the balance between ET1 and NO level. (Med J Indones. 2013;22:161-6. doi: 10.13181/mji.v22i3.585)

References

  1. Poll EM, Bostrom A, Burgel U, et al. Cortisol dynamics in the acute phase of aneurysmal subarachnoid hemorrhage: associated with disease severity and outcome. J Neurotrauma. 2010;27(1):189-195. http://dx.doi.org/10.1089/neu.2009.1014

  2. Suhardja A. Mechanism of disease: Roles of nitric oxide and endothelin -1 in delayed cerebral vasospasm produced by aneurismal subarachnoid hemorrhage. Nature Clinical Practice Cardiovascular Medicine. 2004;1(2):110-116. http://dx.doi.org/10.1038/ncpcardio0046

  3. Bourque SL, Davidge ST, Adams MA. The interaction between endothelin -1 and nitric oxide in the vasculature: new perspectives. AmJ Physiol Regul Integr Comp Physiol. 2011;300(6):R1288-R1295. http://dx.doi.org/10.1152/ajpregu.00397.2010

  4. Morin C, Asselin C, Boudreau F, Provencher PH. Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem Biophys Res Commun. 1998;244(2):583-7. http://dx.doi.org/10.1006/bbrc.1998.8300

  5. Provencher PH, Villeneuve A, Morin C. Glucocorticoids increase preproendothelin-1 expression in rat aorta. Endocr Res.1998;24:737-41. http://dx.doi.org/10.3109/07435809809032679

  6. Korhonen R, Lahti A, Hamalainen M, Kankaanranta H, Moilanen E. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol Pharmacol. 2002;62(3):698-704. http://dx.doi.org/10.1124/mol.62.3.698

  7. Wallerath T, Witte K, Schafer SC, et al. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci U S A. 1999;96(23):13357-62. http://dx.doi.org/10.1073/pnas.96.23.13357

  8. Rogers KM, Bonar CA, Estrella JL, Yang S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol. 2002;283(5):H1922-8.

  9. Thony B, Auerbach G, Blau N. Tetrahydrobipterin biosynthesis, regeneration, and functions. Biochem J. 2000;347:1-26. http://dx.doi.org/10.1042/0264-6021:3470001

  10. Drake CG. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68(6):985-6.

  11. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized y CT Scanning. Neurosurgery. 1980;6(1):1-9. http://dx.doi.org/10.1227/00006123-198001000-00001

  12. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijr J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-7. http://dx.doi.org/10.1161/01.STR.19.5.604

  13. Coolens JL, Van BH, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding Globulin. J Steroid Biochem. 1987;26(2):197-202. http://dx.doi.org/10.1016/0022-4731(87)90071-9

  14. July J, As'ad S, Suhadi B, Islam AA. The association between cortisol dynamics and the course of aneurysmal subarachnoid hemorrhage. Asian J Neurosurg. 2011;6(2):83-87. http://dx.doi.org/10.4103/1793-5482.92166

  15. July J, As'ad S, Suhadi FX, Islam AA. Cortisol dynamics are associated with electrocardiographic abnormalities following the aneurysmal subarachnoid hemorrhage. J Cardiovasc Dis Re. 2012;3(4):315-8. http://dx.doi.org/10.4103/0975-3583.102717

  16. Bendel S, Koivisto T, Ruokonen E, et al. Pituitary-Adrenal function in patients with acute subarachnoid haemorrhage; A prospective cohort study. Crit Care. 2008;12:R126. http://dx.doi.org/10.1186/cc7084

  17. Vergouwen MD, van Geloven N, de Haan RJ, Kruyt ND, Vermeulen M, Roos YB. Increased cortisol levels are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;12(3):342-5. http://dx.doi.org/10.1007/s12028-010-9331-8

  18. Sarrafzadeh A, Schlenk F, Gericke C, Vajkoczy P. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;13(3):339-46. http://dx.doi.org/10.1007/s12028-010-9432-4

  19. Hanafy KA, Grobelny B, Fernandez L, et al. Brain interstitial fluid TNF-alpha after subarachnoid hemorrhage. J Neurol Sci. 2010;291(1-2):69-73. http://dx.doi.org/10.1016/j.jns.2009.12.023

  20. Hizume T, Morikawa K, Takaki A, et al. Sustained elevation of serum kortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo. A possible link between stress and coronary vasospasme. Circ Res. 2006;99(7):767-775. http://dx.doi.org/10.1161/01.RES.0000244093.69985.2f

  21. Pluta RM, Afshar JK, Boock RJ, Oldfield EH. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg. 1998;88(3):557-61. http://dx.doi.org/10.3171/jns.1998.88.3.0557

Published
2013-08-23
How to Cite
1.
July J, Yunus Y, Sungono V, As’adS, Suhadi B, Islam AA. Cortisol dynamics and endothelin-1/nitric oxide ratio are associated with clinical vasospasme. Med J Indones [Internet]. 2013Aug.23 [cited 2024Apr.24];22(3):161-6. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/585
Issue
Vol. 22 No. 3 (2013): August
Section
Clinical Research

Copyright (c) 2013 Julius July, Yesaya Yunus, Veli Sungono, Suryani As’ad, Budhianto Suhadi, Andi A. Islam

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.